Veracyte | VCYT - Stock


Veracyte reported $21.42M in Stock for its fiscal quarter ending in March of 2026.





Stock Change Date
Agilent USD 1.09B 30M Mar/2026
Anika Therapeutics USD 22.84M 4.05M Mar/2026
Arrowhead Research USD -173.08M 173.08M Dec/2024
Bruker USD 1.12B 26.9M Mar/2026
Heron Therapeutics USD 54.57M 2.33M Dec/2022
Illumina USD 611M 47M Mar/2026
Intrexon USD 287K 68K Dec/2022
Karyopharm Therapeutics USD 4.04M 72K Dec/2025
Laboratory Of America USD 497.7M 37M Mar/2026
Ligand Pharmaceuticals USD 13.27M 4.14M Mar/2026
Myriad Genetics USD 27.9M 2.7M Mar/2026
Rigel Pharmaceuticals USD 13.3M 2.88M Sep/2025
Roche Holding CHF 7.6B 9M Jun/2025
Siemens EUR 11.1B 841M Dec/2025
Sonic Healthcare AUD 208.83M 3.83M Jun/2024
Thermo Fisher Scientific USD 5.5B 71M Mar/2026
Veracyte USD 21.42M 870K Mar/2026
Waters USD 1.5B 923.63M Mar/2026